RI
ITOS

RTW Investments’s iTeos Therapeutics ITOS Stock Holding History

RTW Investments’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-489,014
Closed -$15.7M – 112
2022
Q1 		$15.7M Sell
489,014
-1,864,001
-79% -$67.7M 0.33% 58
2021
Q4 		$110M Hold
2,353,015
– – 1.6% 22
2021
Q3 		$63.5M Buy
2,353,015
+636,430
+37% +$16.6M 0.96% 31
2021
Q2 		$44M Sell
1,716,585
-1,046,206
-38% -$24.9M 0.66% 38
2021
Q1 		$94.4M Buy
2,762,791
+1,688,625
+157% +$61M 1.47% 22
2020
Q4 		$36M Buy
1,074,166
+171,311
+19% +$4.54M 0.6% 42
2020
Q3 		$20.9M Buy
+902,855
New +$24.3M 0.5% 48

Other funds holding ITOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

RTW Investments's ITOS Position: Q2 2022 in Review

RTW Investments sold out of iTeos Therapeutics (ITOS) in Q2 2022, closing a stake of 489,014 shares — an estimated $15.7M sold.

RTW Investments first reported a position in ITOS in Q3 2020 and held it in 7 quarters. The position peaked at $110M in Q4 2021. 152 funds tracked by Wall St. Rank hold ITOS as of Q2 2022.

  • RTW Investments reported no remaining iTeos Therapeutics position as of Q2 2022 after selling out during the quarter.
  • RTW Investments sold 489,014 iTeos Therapeutics shares in Q2 2022, an estimated $15.7M.
  • RTW Investments first reported a position in iTeos Therapeutics in Q3 2020 and held it in 7 quarters.
  • RTW Investments's iTeos Therapeutics position peaked at $110M in Q4 2021.
  • 152 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q2 2022.

Based on RTW Investments's 13F filing for Q2 2022, filed 15 Aug 2022.